Macular Dystrophy, Occult Clinical CharacteristicsOcular Features: There is considerable clinical heterogeneity in this disorder. Reduced vision may cause symptoms beginning during adolescence but some individuals may have good vision until the 6th decade or even later. Even those who complain of changes in acuity may still have 20/20 to 20/25 vision but it may also be much worse, in the range of count fingers. There can be considerable asymmetry in acuity between the two eyes but there is little known about the rate of vision loss. Mild dyschromatopsia is often present with deficits in both red-green and red-green discrimination but total color blindness has also been reported. Full field ERGs usually show no rod or cone deficits. However, multifocal ERG changes suggest dysfunction of the cones in the macula. Spectral-domain optical coherence tomography can reveal disruptive changes at the photoreceptor inner/outer segment line and in cone outer segment tips. Disruption of the external limiting membrane and decreased foveal thickness have also been reported. The retina appears normal to clinical examination even in advanced stages of disease and fluorescein angiography likewise shows no abnormalities. Systemic Features: No systemic disease has been repoted in this condition. GeneticsThis is an autosomal dominant condition resulting from heterozygous mutations in RP1L1 (8p23.1). A significant number of sporadic cases occur, however, which suggests new mutations are relatively common or that there is etiologic heterogeneity. Pedigree: Autosomal dominantTreatmentTreatment Options: No treatment is known. ReferencesArticle Title: CLINICAL CHARACTERISTICS OF OCCULT MACULAR DYSTROPHY IN FAMILY WITH MUTATION OF RP1L1 GENE Tsunoda K, Usui T, Hatase T, Yamai S, Fujinami K, Hanazono G, Shinoda K, Ohde H, Akahori M, Iwata T, Miyake Y. CLINICAL CHARACTERISTICS OF OCCULT MACULAR DYSTROPHY IN FAMILY WITH MUTATION OF RP1L1 GENE. Retina. 2012 Jun;32(6):1135-47. PubMed ID: 22466457 Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy Kim YG, Baek SH, Moon SW, Lee HK, Kim US. Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy. Acta Ophthalmol. 2011 Feb;89(1):e52-6. PubMed ID: 20560888 Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography Park SJ, Woo SJ, Park KH, Hwang JM, Chung H. Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3673-9. PubMed ID: 20164460 Read more about Macular Dystrophy, Occult
CLINICAL CHARACTERISTICS OF OCCULT MACULAR DYSTROPHY IN FAMILY WITH MUTATION OF RP1L1 GENE Tsunoda K, Usui T, Hatase T, Yamai S, Fujinami K, Hanazono G, Shinoda K, Ohde H, Akahori M, Iwata T, Miyake Y. CLINICAL CHARACTERISTICS OF OCCULT MACULAR DYSTROPHY IN FAMILY WITH MUTATION OF RP1L1 GENE. Retina. 2012 Jun;32(6):1135-47. PubMed ID: 22466457
Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy Kim YG, Baek SH, Moon SW, Lee HK, Kim US. Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy. Acta Ophthalmol. 2011 Feb;89(1):e52-6. PubMed ID: 20560888
Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography Park SJ, Woo SJ, Park KH, Hwang JM, Chung H. Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3673-9. PubMed ID: 20164460